HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alex H Ramos Selected Research

Neoplasms (Cancer)

4/2015Oncotator: cancer variant annotation tool.
10/2014NAMPT is the cellular target of STF-31-like small-molecule probes.
9/2012Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.
6/2012Sequence analysis of mutations and translocations across breast cancer subtypes.
8/2011The mutational landscape of head and neck squamous cell carcinoma.
6/2011Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.
11/2009SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
11/2009Amplification of chromosomal segment 4q12 in non-small cell lung cancer.
8/2008Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
12/2007Characterizing the cancer genome in lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alex H Ramos Research Topics

Disease

10Neoplasms (Cancer)
04/2015 - 12/2007
4Carcinogenesis
09/2012 - 06/2008
3Adenocarcinoma of Lung
06/2011 - 12/2007
2Prostatic Neoplasms (Prostate Cancer)
04/2013 - 05/2012
2Colorectal Neoplasms (Colorectal Cancer)
09/2012 - 09/2011
2Adenocarcinoma
09/2012 - 09/2011
2Breast Neoplasms (Breast Cancer)
06/2012 - 05/2012
2Carcinoma (Carcinomatosis)
01/2011 - 06/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2009 - 06/2008
1Renal Cell Carcinoma (Grawitz Tumor)
10/2014
1Esophageal Neoplasms (Esophageal Cancer)
09/2012
1Medulloblastoma
08/2012
1Triple Negative Breast Neoplasms
06/2012
1Melanoma (Melanoma, Malignant)
05/2012
1Lung Neoplasms (Lung Cancer)
06/2011
1Multiple Myeloma
03/2011
1Endometrial Neoplasms (Endometrial Cancer)
06/2008

Drug/Important Bio-Agent (IBA)

6DNA (Deoxyribonucleic Acid)IBA
04/2013 - 12/2007
4Transcription Factors (Transcription Factor)IBA
09/2012 - 12/2007
3Phosphotransferases (Kinase)IBA
09/2012 - 06/2008
3Proteins (Proteins, Gene)FDA Link
05/2012 - 02/2011
2CateninsIBA
08/2012 - 09/2011
2Tyrosine (L-Tyrosine)FDA Link
06/2011 - 06/2008
1NucleotidesIBA
04/2015
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
10/2014
1Nicotinamide PhosphoribosyltransferaseIBA
10/2014
1STF-31IBA
10/2014
1Biomarkers (Surrogate Marker)IBA
09/2012
1Histone MethyltransferasesIBA
08/2012
1RNA Helicases (RNA Helicase)IBA
08/2012
1Progesterone Receptors (Progesterone Receptor)IBA
06/2012
1Androgen Receptors (Androgen Receptor)IBA
05/2012
1AndrogensIBA
05/2012
1Discoidin Domain Receptor 2IBA
06/2011
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2011
1Dasatinib (BMS 354825)FDA Link
06/2011
1Proto-Oncogene Proteins B-rafIBA
03/2011
1Platelet-Derived Growth Factor alpha ReceptorIBA
11/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2008
1Aligeron (AS 2)IBA
08/2008
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
06/2008
1EnzymesIBA
06/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2008

Therapy/Procedure

7Therapeutics
09/2012 - 12/2007